Malin Bergqvist1, Karin Elebro1,2, Signe Borgquist1,3,4, Ann H Rosendahl1. 1. Department of Clinical Sciences Lund, Oncology, Lund University, Skåne University Hospital, Lund, Sweden. 2. Department of Clinical Sciences Malmö, Surgery, Lund University, Skåne University Hospital, Malmö, Sweden. 3. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. 4. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Abstract
BACKGROUND: Obesity and associated metabolic conditions impact adipocyte functionality with potential consequences for breast cancer risk and prognosis, but contributing mechanisms remain to be understood. The adipokine receptor adenylyl cyclase-associated protein-1 (CAP1) has been implicated in the progression of breast cancer, but results are conflicting and the underlying molecular mechanisms are still unknown. In this study, molecular and cellular effects in breast cancer cells by stimulation of adipocytes under normal or obese-like conditions, and potential involvement of CAP1, were assessed. MATERIAL AND METHODS: Estrogen receptor (ER)-positive T47D and ER-negative MDA-MB-231 breast cancer cells were exposed to adipocyte-secretome from adipocytes placed under pressures mimicking normal and obese-like metabolic conditions. Changes in phosphorylated kinase proteins and related biological pathways were assessed by phospho-antibody array and PANTHER analysis, cell proliferation were investigated through sulforhodamine B, cell cycle distribution by flow cytometry. Functional effects of CAP1 were subsequently examined following small interfering (si)RNA-mediated knockdown. RESULTS: Protein phosphorylations involved in important biological processes were enriched in T47D breast cancer cells in response to adipocyte secretome from obese-like compared with normal conditions. The obesity-associated adipocyte secretome further stimulated cell proliferation and a shift from cell cycle G1-phase to S- and G2/M-phase was observed. Silencing of CAP1 decreased cell proliferation in both T47D and MDA-MB-231 cells, and reduced the obesity-associated secretome-induction of phosphoproteins involved in cell proliferation pathways. CONCLUSIONS: These results indicate that the adipocyte secretome and CAP1 are mechanistically important for the proliferation of both ER-positive and ER-negative breast cancer cells, and potential signaling mediators were identified. These studies provide biological insight into how obesity-associated factors could affect breast cancer.
BACKGROUND: Obesity and associated metabolic conditions impact adipocyte functionality with potential consequences for breast cancer risk and prognosis, but contributing mechanisms remain to be understood. The adipokine receptor adenylyl cyclase-associated protein-1 (CAP1) has been implicated in the progression of breast cancer, but results are conflicting and the underlying molecular mechanisms are still unknown. In this study, molecular and cellular effects in breast cancer cells by stimulation of adipocytes under normal or obese-like conditions, and potential involvement of CAP1, were assessed. MATERIAL AND METHODS: Estrogen receptor (ER)-positive T47D and ER-negative MDA-MB-231 breast cancer cells were exposed to adipocyte-secretome from adipocytes placed under pressures mimicking normal and obese-like metabolic conditions. Changes in phosphorylated kinase proteins and related biological pathways were assessed by phospho-antibody array and PANTHER analysis, cell proliferation were investigated through sulforhodamine B, cell cycle distribution by flow cytometry. Functional effects of CAP1 were subsequently examined following small interfering (si)RNA-mediated knockdown. RESULTS: Protein phosphorylations involved in important biological processes were enriched in T47D breast cancer cells in response to adipocyte secretome from obese-like compared with normal conditions. The obesity-associated adipocyte secretome further stimulated cell proliferation and a shift from cell cycle G1-phase to S- and G2/M-phase was observed. Silencing of CAP1 decreased cell proliferation in both T47D and MDA-MB-231 cells, and reduced the obesity-associated secretome-induction of phosphoproteins involved in cell proliferation pathways. CONCLUSIONS: These results indicate that the adipocyte secretome and CAP1 are mechanistically important for the proliferation of both ER-positive and ER-negative breast cancer cells, and potential signaling mediators were identified. These studies provide biological insight into how obesity-associated factors could affect breast cancer.
Authors: York Tomita; Natasha Marchenko; Susan Erster; Alice Nemajerova; Alexander Dehner; Christian Klein; Hongguang Pan; Horst Kessler; Petr Pancoska; Ute M Moll Journal: J Biol Chem Date: 2006-01-26 Impact factor: 5.157
Authors: Ann H Rosendahl; Malin Bergqvist; Barbara Lettiero; Siker Kimbung; Signe Borgquist Journal: Front Endocrinol (Lausanne) Date: 2018-11-22 Impact factor: 5.555
Authors: Taekyu Kang; Christina Yau; Christopher K Wong; John Z Sanborn; Yulia Newton; Charlie Vaske; Stephen C Benz; Gregor Krings; Roman Camarda; Jill E Henry; Josh Stuart; Mark Powell; Christopher C Benz Journal: Breast Cancer Res Date: 2020-07-31 Impact factor: 6.466
Authors: Lauren E Hillers-Ziemer; Genevra Kuziel; Abbey E Williams; Brittney N Moore; Lisa M Arendt Journal: Cancer Metastasis Rev Date: 2022-04-18 Impact factor: 9.237
Authors: Marie Klintman; Ann H Rosendahl; Benjamin Randeris; Mikael Eriksson; Kamila Czene; Per Hall; Signe Borgquist Journal: Breast Cancer Res Treat Date: 2022-08-30 Impact factor: 4.624